Journal Article

A functional single nucleotide polymorphism in the core promoter region of <i>CALM1</i> is associated with hip osteoarthritis in Japanese

Hideyuki Mototani, Akihiko Mabuchi, Susumu Saito, Mikihiro Fujioka, Aritoshi Iida, Yoshio Takatori, Akihiro Kotani, Toshikazu Kubo, Kozo Nakamura, Akihiro Sekine, Yoshinori Murakami, Tatsuhiko Tsunoda, Kohei Notoya, Yusuke Nakamura and Shiro Ikegawa

in Human Molecular Genetics

Volume 14, issue 8, pages 1009-1017
Published in print April 2005 | ISSN: 0964-6906
Published online March 2005 | e-ISSN: 1460-2083 | DOI: http://dx.doi.org/10.1093/hmg/ddi093
A functional single nucleotide polymorphism in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese

Show Summary Details

Preview

Osteoarthritis (OA), a common skeletal disease, is a leading cause of disability among the elderly populations. OA is characterized by gradual loss of articular cartilage, but the etiology and pathogenesis of OA are largely unknown. Epidemiological and genetic studies have demonstrated that genetic factors play an important role in OA. To identify susceptibility genes for OA, we performed a large-scale, case–control association study using gene-based single nucleotide polymorphisms (SNPs). In two independent case–control populations, we found significant association (P=9.8×10−7) between hip OA and a SNP (IVS3−293C>T) located in intron 3 of the calmodulin (CaM) 1 gene (CALM1). CALM1 was expressed in cultured chondrocytes and articular cartilage, and its expression was increased in OA. Subsequent linkage-disequilibrium mapping identified five SNPs showing significant association equivalent to IVS3−293C>T. One of these (−16C>T) is located in the core promoter region of CALM1. Functional analyses indicate that the susceptibility −16T allele decreases CALM1 transcription in vitro and in vivo. Inhibition of CaM in chondrogenic cells reduced the expression of the major cartilage matrix genes Col2a1 and Agc1. These results suggest that the transcriptional level of CALM1 is associated with susceptibility for hip OA through modulation of chondrogenic activity. Our findings reveal the CALM1-mediated signaling pathway in chondrocytes as a novel potential target for treatment of OA.

Journal Article.  5785 words.  Illustrated.

Subjects: Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.